IRON.US Disc Medicine Inc.

Healthcare Biotechnology USA Stocks
80.00 USD
Close of Nov 15, 2026
40.00 99.50
Market cap
USD 3.64B
P/E
-
P/B
6.03x
ROE
-40.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is IRON.US undervalued?

Graham number

The Graham number of Disc Medicine Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Disc Medicine Inc. fundamental analysis

No fundamental analysis for Disc Medicine Inc. yet.

Disc Medicine Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Disc Medicine Inc.

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynth…

Full company profile